Table 3.
Anthropometric and metabolic data of new-onset T1DM, LADA, and T2DM patients and NGT subjects.
| NGT (n=80) | T2DM (n=39) | LADA (n=16) | T1DM (n=35) | |
|---|---|---|---|---|
| Age | 50.16 ± 12.66 | 51.27 ± 9.18 | 45.24 ± 14.23 | 34.72 ± 15.49*† |
| Male (%) | 48.75 (39/80) | 53.84 (21/39) | 47.36 (9/19) | 48.78 (20/41) |
| BMI (kg/m2) | 23.88 ± 3.38 | 23.81 ± 3.52 | 21.22 ± 3.14 | 20.17 ± 3.11*†† |
| Waist circumference (cm) | 82.73 ± 10.38 | 86.25 ± 9.37 | 78.76 ± 9.67†† | 76.44 ± 10.15*† |
| Triglyceride (mmol/L) § | 1.13 (0.79, 1.64) | 1.60 (1.05, 2.57)* | 1.22 (0.89, 1.57) | 0.90 (0.77, 1.64)† |
| Cholesterol (mmol/L) | 2.88 ± 0.80 | 2.95 ± 0.78 | 2.90 ± 1.10 | 2.71 ± 1.09 |
| LDL (mmol/L) | 2.74 ± 0.87 | 3.21 ± 1.06* | 2.90 ± 1.10 | 2.70 ± 1.17 |
| FBG (mmol/L) | 5.09 ± 0.52 | 7.59 ± 3.03** | 8.75 ± 5.15 | 9.64 ± 4.46*** |
| HbA1C (%)§ | N/A | 6.15 (5.75,8.45) | 7.4 (5.2,9.72) | 8.7 (7.2,12.5)† |
| HbA1C (mmol/mol) § | N/A | 43 (40,69) | 57 (33,83) | 72 (55,113)† |
| FCP (nmol/L) § | 0.42 (0.34, 0.54) | 0.53 (0.38, 0.77)*** | 0.29 (0.14, 0.49)** | 0.16 (0.04, 0.25)** |
Compared with NGT * p<0.05, **p<0.01,*** p<0.001. Compared with T2D †p<0.05, ††p<0.01. §: Data are expressed as the median values (25th-75th percentiles) and compared by the Kruskal-Wallis test. Other data are the means ± SDs. New-onset: disease duration less than one year. LADA, patients with latent autoimmune diabetes in adults; N/A, not applicable; NGT, normal glucose tolerance subjects; T1D, type 1 diabetic subjects; T2D, type 2 diabetic subjects; BMI, body mass index; LDL, low-density lipoprotein cholesterol; FBG, fasting blood glucose; HbA1c, hemoglobin A1C; FCP, fasting C-peptide.